The expected start time for a joint regulatory scheme for therapeutic products in Australia and New Zealand (NZ) is now the second half of 2007

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1102, 2006-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007

By Ragupathy Rajan  

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 386-393

Springer Publishing Company

Access to resources Recommend Favorite

A Perspective on New Zealand's Medicines Regulatory Environment

By Richardson R.   Shaw I.   Nolan S.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 17-22

Adis International

Access to resources Recommend Favorite

The New Zealand (NZ) Centre for Adverse Reactions Monitoring has received 14 reports of facial skin damage

By  

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Individuals in residential care units in New Zealand (NZ) received a mean of 5.7 medications each in 1999-2000

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Reclassification of orlistat [Xenical; Roche] as a pharmacist-only medicine has been recommended in New Zealand (NZ)

By  

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite